Aug 17, 2020
Immutep Completes Recruitment for Stage 1 of Part B in TACTI-002 Study
Immutep Issues Newsletter Update to Shareholders
Aug 11, 2020
Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
Jul 22, 2020
Immutep Quarterly Activities Report
Jul 13, 2020
Immutep Announces United States Patent Grant for IMP701 Antibody
Jun 28, 2020
Immutep Completes Recruitment for Part A Of Phase II TACTI-002 Study
Jun 21, 2020
Immutep Receives A$1,437,826 R&D Tax Incentive
May 30, 2020
Immutep Announces Improving Data from the Phase II TACTI-002 Study
Immutep Reports First Results from INSIGHT-004 Study
May 27, 2020
Immutep Receives US$2.4 Million R&D Tax Incentive from French Government
May 25, 2020
Immutep Global Webcast to Present New Data from 2020 ASCO Annual Meeting
May 06, 2020
Immutep Granted Japanese Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
